HomeFOLD • NASDAQ
add
Amicus Therapeutics, Inc.
Previous close
$14.34
Day range
$14.32 - $14.37
Year range
$5.51 - $14.38
Market cap
4.51B USD
Avg Volume
7.39M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 185.21M | 23.72% |
Operating expense | 142.72M | 20.03% |
Net income | 1.69M | -88.53% |
Net profit margin | 0.91 | -90.76% |
Earnings per share | 0.10 | 11.11% |
EBITDA | 17.84M | -0.94% |
Effective tax rate | 46.23% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 293.54M | 17.44% |
Total assets | 949.87M | 21.00% |
Total liabilities | 675.63M | 14.32% |
Total equity | 274.24M | — |
Shares outstanding | 314.00M | — |
Price to book | 16.30 | — |
Return on assets | 4.38% | — |
Return on capital | 5.74% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 1.69M | -88.53% |
Cash from operations | 16.25M | 515.04% |
Cash from investing | -6.49M | 68.15% |
Cash from financing | 14.03M | 1,178.85% |
Net change in cash | 23.46M | 216.69% |
Free cash flow | 18.09M | 109.11% |
About
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates. Wikipedia
Founded
Feb 4, 2002
Website
Employees
499
